11/12/24 08:01 | 11/11/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Marucci Anthony S | NJ | DO | P,CEO | P | 308 | 26.82 | 0 | 12 | 40 | 40 | D | | | | | | | | | | | | | | |
10/15/24 09:21 | 10/11/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | P | 200 | 13.80 | 0 | 15 | 7 | 216 | D | | | | | | | | | | | | | | |
10/9/24 13:18 | 9/6/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Timur | IL | O | CTO | P.a | 20 | 0.2900 | 0 | 69 | 54 | 197 | D | | | | | | | | | | | | | | |
10/8/24 10:42 | 9/6/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Meeshanthini | IL | DO | CEO | P.a | 20 | 0.2900 | 0 | 69 | 4 | 1,655 | D | | | | | | | | | | | | | | |
10/7/24 11:29 | 9/6/24 | NUTX | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Meeshanthini | IL | DO | CEO | P.a | 20 | 0.2900 | 0 | 69 | 4 | 1,655 | D | | | | | | | | | | | | | | |
10/4/24 19:40 | 10/2/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | James Andrea S. | CA | O | CFO | P | 100 | 2.97 | 0 | 34 | New | 34 | D | | | | | | | | | | | | | | |
10/4/24 19:00 | 10/2/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Broadwood Partners, L.P. | NY | T | | P.d | 3,878 | 2.95 | 0 | 1,315 | 12 | 12,489 | M | | | | | | | | | | | | | | |
9/23/24 16:24 | 9/6/24 | NUTX | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Timur | IL | O | CTO | P.a | 20 | 0.2900 | 0 | 69 | 54 | 197 | D | | | | | | | | | | | | | | |
9/10/24 17:22 | 9/6/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Philibert Robert | IL | DO | Chief Me | P | 10 | 0.2865 | 0 | 34 | 2 | 1,684 | I | | | | | | | | | | | | | | |
9/9/24 11:08 | 9/6/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Meeshanthini | IL | O | CTO | P | 20 | 0.2900 | 0 | 69 | 54 | 197 | D | | | | | | | | | | | | | | |
9/9/24 11:01 | 9/6/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Meeshanthini | IL | DO | CEO | P | 20 | 0.2900 | 0 | 69 | 4 | 1,684 | D | | | | | | | | | | | | | | |
8/21/24 08:26 | 8/20/24 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | | P | 101 | 0.6700 | 0 | 150 | 6 | 2,781 | D | | | | | | | | | | | | | | |
8/7/24 10:17 | 8/6/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Tobin James P | MI | D | | P | 51 | 16.86 | 0 | 3 | 15 | 23 | D | | | | | | | | | | | | | | |
7/16/24 21:13 | 7/12/24 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Telegraph Hill Partners Iv, L.P. | CA | T | | P | 15,000 | 1.24 | 0 | 12,097 | 83 | 26,591 | I | | | | | | | | | | | | | | |
7/16/24 17:15 | 7/12/24 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lowell Matthew | CA | O | CFO | P | 50 | 1.24 | 0 | 40 | 46 | 128 | D | | | | | | | | | | | | | | |
7/16/24 17:15 | 7/12/24 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gunstream Stephen | CA | DO | P,CEO | P | 100 | 1.24 | 0 | 81 | 50 | 243 | D | | | | | | | | | | | | | | |
7/11/24 17:15 | 7/9/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schuler Jack W | IL | T | | P.d | 0 | 0.00 | 0 | 7 | 0 | 1,919 | D | | | | | | | | | | | | | | |
6/18/24 16:12 | 1/26/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schuler Jack W | IL | T | | P.d | 0 | 0.00 | 0 | 29 | 2 | 1,912 | I | | | | | | | | | | | | | | |
6/3/24 17:30 | 5/31/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandford Nicole | TX | DO | CEO | P | 23 | 2.42 | 0 | 9 | 16 | 71 | D | | | | | | | | | | | | | | |
4/17/24 12:04 | 4/17/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | COO | P | 124 | 12.36 | 0 | 10 | 28 | 46 | D | | | | | | | | | | | | | | |
4/15/24 19:21 | 4/11/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Broadwood Partners, L.P. | NY | T | | P.d | 7,058 | 2.92 | 0 | 2,420 | 33 | 9,858 | M | | | | | | | | | | | | | | |
4/15/24 06:04 | 4/11/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Riggs Josh | CA | DO | CEO,P | P | 10 | 2.95 | 0 | 3 | 999% | 4 | D | | | | | | | | | | | | | | |
4/15/24 06:02 | 4/11/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Arno Andrew | CA | D | | P | 100 | 2.95 | 0 | 34 | 67 | 85 | D | | | | | | | | | | | | | | |
4/11/24 11:40 | 4/11/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Borel James C | DE | D | | P | 98 | 13.06 | 0 | 8 | 54 | 21 | D | | | | | | | | | | | | | | |
4/10/24 16:18 | 4/10/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Naemura David H. | MI | O | CFO | P | 156 | 12.51 | 0 | 13 | 71 | 30 | D | | | | | | | | | | | | | | |
4/10/24 14:25 | 4/10/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | P | 284 | 12.36 | 0 | 23 | 18 | 152 | D | | | | | | | | | | | | | | |
3/8/24 11:24 | 3/6/24 | CATX | Perspective Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lantheus Alpha Therapy, LLC | MA | T | | P | 57,409 | 0.9500 | 0 | 60,431 | 107 | 116,773 | D | | | | | | | | | | | | | | |
3/6/24 16:49 | 3/4/24 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Stewart Richard Alistair | WA | DO | Exec CB | P.d | 46 | 4.59 | 0 | 10 | 35 | 39 | D | | | | | | | | | | | | | | |
3/6/24 16:43 | 3/4/24 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | DO | CEO | P.d | 46 | 4.59 | 0 | 10 | 15 | 77 | D | | | | | | | | | | | | | | |
2/27/24 16:21 | 8/15/22 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Grossman Paul David | CA | D | | P.m | 50 | 5.37 | 0 | 9 | New | 9 | D | | | | | | | | | | | | | | |
2/26/24 18:48 | 2/23/24 | QDEL | Quidelortho Corp | | Health | Diagn | In Vitro & In Vivo Diagnostic | Busky Joseph M | CA | O | CFO | P | 100 | 46.36 | 0 | 2 | 54 | 6 | I | | | | | | | | | | | | | | |
1/30/24 20:31 | 1/26/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandford Nicole | TX | DO | P,CEO | P.d | 0 | 0.00 | 0 | 2 | 4 | 61 | D | | | | | | | | | | | | | | |
12/19/23 10:59 | 12/18/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 8 | 0.8300 | 0 | 10 | 4 | 278 | D | | | | | | | | | | | | | | |
12/18/23 09:38 | 12/15/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 8 | 0.7700 | 0 | 10 | 4 | 268 | D | | | | | | | | | | | | | | |
12/14/23 09:11 | 12/13/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Rootsaert Rodney Gerard | NV | O | Secretar | P | 6 | 0.6000 | 0 | 10 | 1 | 1,086 | D | | | | | | | | | | | | | | |
12/11/23 08:51 | 12/8/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | NV | DO | P,CEO | P | 7 | 0.6700 | 0 | 10 | 0 | 2,746 | D | | | | | | | | | | | | | | |
12/6/23 17:21 | 12/6/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandford Nicole | TX | DO | P,CEO | P | 17 | 3.36 | 0 | 5 | 9 | 59 | D | | | | | | | | | | | | | | |
12/1/23 17:44 | 11/30/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gelhaus Ken | CA | O | Chief Co | P | 6 | 1.73 | 0 | 4 | 19 | 23 | D | | | | | | | | | | | | | | |
11/28/23 09:39 | 11/27/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | | P | 15 | 0.7700 | 0 | 20 | 1 | 2,601 | D | | | | | | | | | | | | | | |
11/28/23 09:39 | 11/27/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Futcher Edward | NV | D | | P | 7 | 0.8000 | 0 | 9 | 2 | 428 | D | | | | | | | | | | | | | | |
11/27/23 10:28 | 11/24/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | | P | 8 | 0.7600 | 0 | 10 | 0 | 2,581 | D | | | | | | | | | | | | | | |
11/24/23 11:06 | 11/22/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | | P | 14 | 0.7100 | 0 | 20 | 1 | 2,571 | D | | | | | | | | | | | | | | |
11/17/23 10:01 | 11/16/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 8 | 0.8100 | 0 | 10 | 4 | 258 | D | | | | | | | | | | | | | | |
11/3/23 13:59 | 11/3/23 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Boehm William T | | D | | P | 32 | 16.06 | 0 | 2 | 8 | 27 | D | | | | | | | | | | | | | | |
10/26/23 08:01 | 10/25/23 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | COO | P | 152 | 15.17 | 0 | 10 | 38 | 36 | D | | | | | | | | | | | | | | |
10/12/23 16:01 | 10/12/23 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Tobin James P | MI | D | | P | 46 | 15.19 | 0 | 3 | 17 | 20 | D | | | | | | | | | | | | | | |
10/11/23 16:21 | 10/11/23 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Naemura David H. | MI | O | CFO | P | 150 | 15.03 | 0 | 10 | New | 10 | D | | | | | | | | | | | | | | |
9/21/23 20:58 | 9/19/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Telegraph Hill Partners Iv, L.P. | CA | T | | P | 15,000 | 1.85 | 0 | 8,108 | 46 | 25,621 | M | | | | | | | | | | | | | | |
9/21/23 17:04 | 9/19/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Terrill Damon | CA | O | GC,CCO | P | 50 | 1.85 | 0 | 27 | 193 | 41 | D | | | | | | | | | | | | | | |
9/21/23 17:04 | 9/19/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mackowski J Matthew | CA | D | | P | 1,500 | 1.85 | 0 | 811 | 999% | 821 | I | | | | | | | | | | | | | | |
9/21/23 17:03 | 9/19/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lowell Matthew | CA | O | CFO | P | 100 | 1.85 | 0 | 54 | 159 | 88 | D | | | | | | | | | | | | | | |
9/21/23 17:03 | 9/19/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gunstream Stephen | CA | DO | P,CEO | P | 100 | 1.85 | 0 | 54 | 50 | 163 | D | | | | | | | | | | | | | | |
9/19/23 16:05 | 8/31/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Henshall Mickie | NV | D | | P | 5 | 1.25 | 0 | 4 | 25 | 19 | D | | | | | | | | | | | | | | |
9/12/23 18:37 | 9/8/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hombeck Torsten | TX | O | CFO | P | 10 | 4.30 | 0 | 2 | 298 | 3 | D | | | | | | | | | | | | | | |
9/8/23 12:18 | 8/25/23 | CDIO | Cardio Diagnostics Holdings, Inc. | | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Meeshanthini | IL | DOT | CEO | P.m | 10 | 0.5460 | 0 | 18 | 17 | 128 | I | | | | | | | | | | | | | | |
9/8/23 12:12 | 8/25/23 | CDIO | Cardio Diagnostics Holdings, Inc. | | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Timur | IL | O | CTO | P.m | 10 | 0.5460 | 0 | 18 | 17 | 128 | D | | | | | | | | | | | | | | |
9/6/23 10:01 | 9/5/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Barnes Phillip | NV | D | | P | 7 | 1.30 | 0 | 5 | 25 | 25 | D | | | | | | | | | | | | | | |
9/5/23 16:14 | 8/24/23 | CDIO | Cardio Diagnostics Holdings, Inc. | | Health | Diagn | In Vitro & In Vivo Diagnostic | Philibert Robert | IL | DOT | Chief Me | P.m | 20 | 0.5999 | 0 | 34 | 1 | 3,282 | I | | | | | | | | | | | | | | |
9/1/23 09:41 | 8/31/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Faulkes Martin Charles | NV | D | | P | 12 | 1.28 | 0 | 10 | 0 | 2,030 | D | | | | | | | | | | | | | | |
8/31/23 09:35 | 8/29/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Micallef Jacob Vincent | NV | O | Chief Sc | P.m | 25 | 1.25 | 0 | 20 | 6 | 328 | I | | | | | | | | | | | | | | |
8/28/23 10:07 | 8/25/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Micallef Jacob Vincent | NV | O | Chief Sc | P | 25 | 1.24 | 0 | 20 | 7 | 308 | D | | | | | | | | | | | | | | |
8/25/23 11:49 | 8/24/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Kway Jasmine | NV | O | CEO - Si | P | 6 | 1.20 | 0 | 5 | 6 | 87 | I | | | | | | | | | | | | | | |
8/25/23 11:49 | 8/24/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Futcher Edward | NV | D | | P | 6 | 1.22 | 0 | 5 | 1 | 419 | D | | | | | | | | | | | | | | |
8/24/23 17:58 | 8/24/23 | MYMD | Mymd Pharmaceuticals, Inc. | NJ | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivard Paul | MD | O | GC | P | 167 | 1.11 | 0 | 150 | 60 | 400 | D | | | | | | | | | | | | | | |
8/24/23 12:00 | 8/24/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Michel Gaetan | NV | O | COO | P | 6 | 1.23 | 0 | 5 | 2 | 213 | D | | | | | | | | | | | | | | |
8/18/23 16:21 | 8/17/23 | MYMD | Mymd Pharmaceuticals, Inc. | NJ | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivard Paul | MD | O | GC | P | 28 | 1.12 | 0 | 25 | 11 | 250 | D | | | | | | | | | | | | | | |
8/17/23 09:40 | 8/16/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 10 | 1.21 | 0 | 8 | 3 | 254 | D | | | | | | | | | | | | | | |
8/16/23 12:28 | 8/16/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | NV | DO | P,CEO | P | 12 | 1.22 | 0 | 10 | 0 | 2,536 | D | | | | | | | | | | | | | | |
7/26/23 19:28 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Fralick Celeste Rachelle | TX | D | | P | 3 | 3.98 | 0 | 1 | 7 | 12 | D | | | | | | | | | | | | | | |
7/26/23 16:28 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Vos Ellen O'Connor | CT | D | | P | 15 | 3.98 | 0 | 4 | 13 | 33 | D | | | | | | | | | | | | | | |
7/25/23 17:39 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schuler Jack W | IL | T | | P | 500 | 2.75 | 0 | 182 | 11 | 1,884 | I | | | | | | | | | | | | | | |
7/25/23 17:20 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cavanaugh Stefanie L. | TX | D | | P | 25 | 3.98 | 0 | 6 | 22 | 35 | D | | | | | | | | | | | | | | |
7/25/23 17:16 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandford Nicole | TX | DO | P,CEO | P | 50 | 3.98 | 0 | 13 | 10 | 135 | D | | | | | | | | | | | | | | |
7/25/23 17:11 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Phan Ryan Thinh | TX | O | CSO,COO | P | 2 | 3.98 | 0 | 1 | 19 | 4 | D | | | | | | | | | | | | | | |
7/25/23 17:03 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Parnell Winfred | TX | D | | P | 25 | 3.98 | 0 | 6 | 25 | 32 | D | | | | | | | | | | | | | | |
7/25/23 16:58 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Merchant Minh Hoang | TX | O | GC,secre | P | 3 | 3.98 | 0 | 1 | 18 | 5 | M | | | | | | | | | | | | | | |
7/24/23 18:58 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Jordan Veronica Gh | TX | D | | P | 15 | 3.98 | 0 | 4 | 12 | 35 | D | | | | | | | | | | | | | | |
7/24/23 18:53 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hombeck Torsten | TX | O | CFO | P | 3 | 3.98 | 0 | 1 | New | 1 | D | | | | | | | | | | | | | | |
7/24/23 18:49 | 7/24/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Herchuk Jannie Prestridge | TX | D | | P | 35 | 3.98 | 0 | 9 | 58 | 24 | D | | | | | | | | | | | | | | |
6/26/23 10:27 | 4/25/23 | NYMX | Nymox Pharmaceutical Corp | | Health | Diagn | In Vitro & In Vivo Diagnostic | Robinson James George | MD | DT | | P.am | 37 | 0.4600 | 0 | 80 | 2 | 4,782 | D | | | | | | | | | | | | | | |
6/15/23 20:13 | 6/14/23 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Kingsley Alfred D | NY | D | | P | 6 | 0.2149 | 0 | 30 | 6 | 563 | D | | | | | | | | | | | | | | |
6/6/23 10:14 | 6/2/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 16 | 1.59 | 0 | 10 | 5 | 217 | D | | | | | | | | | | | | | | |
6/1/23 17:42 | 5/30/23 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | DO | CEO | P | 28 | 5.50 | 0 | 5 | 8 | 67 | D | | | | | | | | | | | | | | |
5/31/23 17:16 | 5/26/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Davis Ted | CA | DT | | P | 6 | 3.22 | 0 | 2 | 0 | 3,576 | D | | | | | | | | | | | | | | |
5/31/23 17:16 | 5/26/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Davis Irene | CA | DT | | P | 6 | 3.22 | 0 | 2 | 0 | 3,576 | I | | | | | | | | | | | | | | |
5/26/23 12:23 | 5/24/23 | BMRA | Biomerica Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Irani Zackary S. | CA | DO | CEO | P.m | 1 | 1.59 | 0 | 1 | 0 | 1,021 | D | | | | | | | | | | | | | | |
5/18/23 16:09 | 4/25/23 | NYMX | Nymox Pharmaceutical Corp | | Health | Diagn | In Vitro & In Vivo Diagnostic | Robinson James George | MD | DT | | P.a | 18 | 0.4500 | 0 | 40 | 1 | 4,742 | D | | | | | | | | | | | | | | |
5/16/23 19:07 | 5/12/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gunstream Stephen | CA | DO | P,CEO | P | 8 | 1.67 | 0 | 5 | 4 | 109 | D | | | | | | | | | | | | | | |
5/16/23 19:07 | 5/12/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gelhaus Ken | CA | O | Chief Co | P | 7 | 1.67 | 0 | 4 | 25 | 19 | D | | | | | | | | | | | | | | |
5/16/23 19:07 | 5/12/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hood Lisa | CA | O | Chief Pe | P | 5 | 1.67 | 0 | 3 | 7 | 48 | D | | | | | | | | | | | | | | |
5/12/23 16:39 | 5/12/23 | BMRA | Biomerica Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Irani Zackary S. | CA | DO | CEO | P | 2 | 1.17 | 0 | 2 | 0 | 1,020 | D | | | | | | | | | | | | | | |
5/12/23 16:06 | 5/10/23 | BMRA | Biomerica Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Irani Zackary S. | CA | DO | CEO | P | 1 | 1.27 | 0 | 1 | 0 | 1,018 | D | | | | | | | | | | | | | | |
5/10/23 17:28 | 5/9/23 | BMRA | Biomerica Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Irani Zackary S. | CA | DO | CEO | P | 0 | 1.39 | 0 | 0 | 0 | 1,018 | D | | | | | | | | | | | | | | |
5/5/23 14:38 | 5/4/23 | BMRA | Biomerica Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Irani Zackary S. | CA | DO | CEO | P | 1 | 1.36 | 0 | 1 | 0 | 1,017 | D | | | | | | | | | | | | | | |
5/1/23 09:15 | 4/27/23 | BMRA | Biomerica Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Irani Zackary S. | CA | DO | CEO | P.m | 6 | 1.32 | 0 | 4 | 0 | 1,017 | D | | | | | | | | | | | | | | |
4/27/23 08:55 | 4/26/23 | BMRA | Biomerica Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Irani Zackary S. | CA | DO | CEO | P | 9 | 1.26 | 0 | 7 | 1 | 1,013 | D | | | | | | | | | | | | | | |
4/7/23 17:12 | 4/5/23 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Pura Vida Investments, LLC | NY | T | | P | 200 | 0.3017 | 0 | 663 | 5 | 14,829 | I | | | | | | | | | | | | | | |
4/5/23 21:35 | 4/3/23 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Broadwood Partners, L.P. | NY | T | | P.d | 8,094 | 0.3017 | 0 | 26,828 | 36 | 100,366 | M | | | | | | | | | | | | | | |
2/23/23 15:54 | 2/22/23 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | | P | 410 | 1.75 | 0 | 234 | 12 | 2,235 | I | | | | | | | | | | | | | | |
1/31/23 10:06 | 1/27/23 | BMRA | Biomerica Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Barbieri Allen | CA | DO | Exec Vic | P | 5 | 2.94 | 0 | 2 | 2 | 101 | D | | | | | | | | | | | | | | |
1/30/23 11:36 | 1/26/23 | BMRA | Biomerica Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Coste Catherine | CA | DH | Audit Co | P | 6 | 2.96 | 0 | 2 | 5 | 44 | D | | | | | | | | | | | | | | |
1/26/23 12:16 | 1/25/23 | BMRA | Biomerica Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Irani Zackary S. | CA | DO | CEO | P | 5 | 2.85 | 0 | 2 | 0 | 1,006 | D | | | | | | | | | | | | | | |
1/25/23 11:36 | 1/24/23 | BMRA | Biomerica Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Irani Zackary S. | CA | DO | CEO | P | 6 | 2.81 | 0 | 2 | 0 | 1,004 | D | | | | | | | | | | | | | | |
1/18/23 17:04 | 1/13/23 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | COO | P | 45 | 17.91 | 0 | 3 | 27 | 12 | D | | | | | | | | | | | | | | |
1/9/23 16:38 | 1/6/23 | HSKA | Heska Corp | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Wilson Kevin S. | CO | DO | CEO,P | P | 646 | 58.62 | 0 | 11 | 2 | 478 | D | | | | | | | | | | | | | | |
12/28/22 16:05 | 12/23/22 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Arno Andrew | CA | D | | P | 88 | 0.3515 | 0 | 250 | 80 | 562 | D | | | | | | | | | | | | | | |
12/28/22 16:05 | 12/23/22 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Gutfreund John Peter | CA | D | | P | 25 | 0.3297 | 0 | 75 | New | 75 | I | | | | | | | | | | | | | | |
12/27/22 18:47 | 12/22/22 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Kingsley Alfred D | NY | D | | P | 7 | 0.2850 | 0 | 25 | 5 | 533 | D | | | | | | | | | | | | | | |
12/27/22 12:45 | 12/22/22 | HSKA | Heska Corp | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Wilson Kevin S. | CO | DO | CEO,P | P | 205 | 59.64 | 0 | 3 | 1 | 467 | D | | | | | | | | | | | | | | |
12/20/22 10:30 | 12/19/22 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 11 | 2.27 | 0 | 5 | 3 | 198 | D | | | | | | | | | | | | | | |
12/20/22 10:04 | 12/16/22 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Micallef Jacob Vincent | NV | O | Chief Sc | P.m | 72 | 2.22 | 0 | 32 | 14 | 262 | D | | | | | | | | | | | | | | |
12/19/22 09:59 | 12/16/22 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Faulkes Martin Charles | NV | D | | P | 116 | 2.10 | 0 | 55 | 3 | 1,993 | D | | | | | | | | | | | | | | |
12/13/22 09:59 | 12/12/22 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 9 | 2.09 | 0 | 4 | 2 | 193 | D | | | | | | | | | | | | | | |
12/12/22 09:53 | 12/8/22 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Plummer Nicholas | NV | O | GC - Vol | P | 10 | 2.07 | 0 | 5 | 10 | 51 | D | | | | | | | | | | | | | | |
12/8/22 20:24 | 12/8/22 | MYMD | Mymd Pharmaceuticals, Inc. | NJ | Health | Diagn | In Vitro & In Vivo Diagnostic | Rivard Paul | MD | O | EVP of O | P | 15 | 1.53 | 0 | 10 | 5 | 225 | D | | | | | | | | | | | | | | |
11/29/22 10:57 | 11/28/22 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 11 | 2.21 | 0 | 5 | 3 | 188 | D | | | | | | | | | | | | | | |
11/21/22 14:27 | 11/18/22 | ACHV | Achieve Life Sciences, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bencich John | WA | DO | CEO | P.d | 0 | 0.00 | 0 | 22 | 147 | 37 | D | | | | | | | | | | | | | | |
11/17/22 19:46 | 5/13/22 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hood Lisa | CA | O | Chief Pe | P.dm | 17 | 6.07 | 0 | 3 | 10 | 31 | D | | | | | | | | | | | | | | |
11/17/22 19:46 | 5/13/22 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gunstream Stephen | CA | DO | P,CEO | P.dm | 21 | 7.11 | 0 | 3 | 5 | 61 | D | | | | | | | | | | | | | | |
11/17/22 19:45 | 11/14/22 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gelhaus Ken | CA | O | Chief Co | P.d | 6 | 4.23 | 0 | 1 | New | 1 | D | | | | | | | | | | | | | | |
10/11/22 19:09 | 10/11/22 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Quinlan Steven J. | MI | O | VP,CFO | P | 58 | 11.63 | 0 | 5 | 18 | 33 | D | | | | | | | | | | | | | | |
10/4/22 18:43 | 10/3/22 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Boehm William T | | D | | P | 28 | 13.89 | 0 | 2 | 9 | 23 | D | | | | | | | | | | | | | | |
9/28/22 17:29 | 9/28/22 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | COO | P | 100 | 14.31 | 0 | 7 | 254 | 10 | D | | | | | | | | | | | | | | |
9/28/22 17:27 | 9/28/22 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | CO | DO | P,CEO | P | 316 | 14.37 | 0 | 22 | 38 | 80 | D | | | | | | | | | | | | | | |
9/20/22 09:47 | 9/19/22 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Micallef Jacob Vincent | NV | O | Chief Sc | P | 22 | 1.70 | 0 | 13 | 6 | 222 | I | | | | | | | | | | | | | | |
9/19/22 14:34 | 9/15/22 | LHDX | Lucira Health, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Engelson Erik T. | CA | DO | P,Chief | P | 36 | 1.82 | 0 | 20 | 7 | 321 | D | | | | | | | | | | | | | | |
9/15/22 16:35 | 9/15/22 | QTNT | Quotient Ltd | Y9 | Health | Diagn | In Vitro & In Vivo Diagnostic | Von Prondzynski Heino | Y9 | D | | P.d | 140 | 0.2000 | 0 | 700 | 99 | 1,406 | D | | | | | | | | | | | | | | |
9/14/22 16:05 | 9/13/22 | QTNT | Quotient Ltd | Y9 | Health | Diagn | In Vitro & In Vivo Diagnostic | Von Prondzynski Heino | Y9 | D | | P.d | 19 | 0.1850 | 0 | 100 | 17 | 706 | D | | | | | | | | | | | | | | |
9/9/22 06:10 | 9/6/22 | QTNT | Quotient Ltd | Y9 | Health | Diagn | In Vitro & In Vivo Diagnostic | Von Prondzynski Heino | Y9 | D | | P.d | 17 | 0.1689 | 0 | 100 | 20 | 606 | D | | | | | | | | | | | | | | |
9/6/22 16:35 | 9/1/22 | QTNT | Quotient Ltd | Y9 | Health | Diagn | In Vitro & In Vivo Diagnostic | Von Prondzynski Heino | Y9 | D | | P.d | 18 | 0.1810 | 0 | 100 | 25 | 506 | D | | | | | | | | | | | | | | |
9/2/22 16:34 | 9/1/22 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lowell Matthew | CA | O | CFO | P | 46 | 4.61 | 0 | 10 | 100 | 20 | D | | | | | | | | | | | | | | |
8/30/22 11:19 | 8/30/22 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Reynolds Cameron John | NV | DO | P,CEO | P | 6 | 1.61 | 0 | 4 | 0 | 2,237 | D | | | | | | | | | | | | | | |
8/30/22 10:14 | 8/26/22 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Micallef Jacob Vincent | NV | O | Chief Sc | P | 50 | 1.74 | 0 | 29 | 16 | 209 | D | | | | | | | | | | | | | | |
8/30/22 09:17 | 8/25/22 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Merchant Minh Hoang | TX | O | GC,Secre | P.d | 0 | 0.00 | 0 | 27 | 77 | 61 | M | | | | | | | | | | | | | | |
8/29/22 21:57 | 8/25/22 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Fralick Celeste Rachelle | TX | D | | P.d | 0 | 0.00 | 0 | 7 | 7 | 103 | D | | | | | | | | | | | | | | |
8/29/22 21:51 | 8/25/22 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Auerbach Robert D | TX | D | | P.d | 0 | 0.00 | 0 | 67 | 122 | 121 | D | | | | | | | | | | | | | | |
8/29/22 21:46 | 8/25/22 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Phan Ryan Thinh | TX | O | CSO,COO | P.d | 0 | 0.00 | 0 | 47 | 999% | 50 | D | | | | | | | | | | | | | | |
8/29/22 21:39 | 8/25/22 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sharma Ruby | TX | D | | P.d | 0 | 0.00 | 0 | 13 | 12 | 128 | D | | | | | | | | | | | | | | |
8/29/22 21:28 | 8/25/22 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandford Nicole | TX | DO | P,CEO | P.d | 0 | 0.00 | 0 | 67 | 120 | 122 | D | | | | | | | | | | | | | | |
8/29/22 17:37 | 8/25/22 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schuler Jack W | IL | T | | P.d | 0 | 0.00 | 0 | 133 | 1 | 25,528 | I | | | | | | | | | | | | | | |
8/25/22 17:10 | 8/24/22 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mackowski J Matthew | CA | D | | P | 50 | 4.98 | 0 | 10 | New | 10 | I | | | | | | | | | | | | | | |
8/24/22 10:52 | 8/23/22 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 8 | 1.60 | 0 | 5 | 3 | 172 | D | | | | | | | | | | | | | | |
8/23/22 11:14 | 8/22/22 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | NV | O | CEO - Vo | P | 8 | 1.64 | 0 | 5 | 3 | 167 | D | | | | | | | | | | | | | | |
8/19/22 08:00 | 8/17/22 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Last Andrew J. | CA | D | | P | 17 | 0.8700 | 0 | 20 | 40 | 70 | D | | | | | | | | | | | | | | |
8/19/22 08:00 | 8/17/22 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Arno Andrew | CA | D | | P | 14 | 0.9000 | 0 | 15 | New | 15 | I | | | | | | | | | | | | | | |
8/18/22 16:05 | 8/16/22 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Andrews Ronald Asbury | CA | DO | P,CEO | P | 38 | 0.9600 | 0 | 40 | 14 | 333 | D | | | | | | | | | | | | | | |
8/17/22 20:20 | 8/15/22 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Kingsley Alfred D | NY | D | | P.d | 10 | 0.9700 | 0 | 10 | 2 | 508 | D | | | | | | | | | | | | | | |
8/17/22 20:19 | 8/15/22 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Gutfreund John Peter | CA | D | | P.d | 23 | 0.9300 | 0 | 25 | 250 | 35 | M | | | | | | | | | | | | | | |
8/17/22 20:18 | 8/16/22 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Griffith Melinda | CA | D | | P.d | 10 | 1.00 | 0 | 10 | 50 | 30 | D | | | | | | | | | | | | | | |
8/17/22 20:17 | 8/16/22 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Carter Jennifer L. | CA | D | | P.d | 10 | 0.9500 | 0 | 11 | 53 | 31 | D | | | | | | | | | | | | | | |
8/17/22 20:15 | 8/15/22 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Arno Andrew | CA | D | | P.dm | 144 | 0.9608 | 0 | 150 | 114 | 282 | D | | | | | | | | | | | | | | |
8/17/22 20:15 | 8/16/22 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Vetter Darci L | MI | D | | P | 24 | 21.83 | 0 | 1 | 387 | 1 | D | | | | | | | | | | | | | | |
8/15/22 18:54 | 8/15/22 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gunstream Stephen | CA | DO | P,CEO | P | 92 | 5.13 | 0 | 18 | New | 18 | D | | | | | | | | | | | | | | |
8/10/22 14:27 | 7/27/22 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Borel James C | DE | D | | P | 148 | 22.70 | 0 | 7 | 123 | 12 | D | | | | | | | | | | | | | | |
8/4/22 19:03 | 8/2/22 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Green Ronald D | MI | D | | P | 34 | 22.50 | 0 | 2 | 16 | 11 | D | | | | | | | | | | | | | | |
8/4/22 16:01 | 8/2/22 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | NV | D | | P | 625 | 2.00 | 0 | 313 | 17 | 2,118 | M | | | | | | | | | | | | | | |
8/2/22 14:28 | 7/29/22 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | CO | DO | P,CEO | P | 404 | 23.07 | 0 | 18 | 43 | 58 | D | | | | | | | | | | | | | | |
7/28/22 13:04 | 7/27/22 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Tobin James P | MI | D | | P | 46 | 22.98 | 0 | 2 | 17 | 14 | D | | | | | | | | | | | | | | |
7/6/22 16:35 | 6/24/22 | QTNT | Quotient Ltd | Y9 | Health | Diagn | In Vitro & In Vivo Diagnostic | Shroff Zubeen | CT | D | | P.d | 1,400 | 0.3000 | 0 | 4,667 | 63 | 12,114 | I | | | | | | | | | | | | | | |
7/6/22 16:35 | 6/24/22 | QTNT | Quotient Ltd | Y9 | Health | Diagn | In Vitro & In Vivo Diagnostic | Wilkerson L John | CT | D | | P.d | 1,400 | 0.3000 | 0 | 4,667 | 63 | 12,091 | I | | | | | | | | | | | | | | |
7/5/22 16:35 | 6/30/22 | QTNT | Quotient Ltd | Y9 | Health | Diagn | In Vitro & In Vivo Diagnostic | Hallsworth Frederick | Y9 | D | | P.d | 20 | 0.2361 | 0 | 85 | 63 | 219 | D | | | | | | | | | | | | | | |
6/28/22 19:46 | 4/14/22 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Pura Vida Investments, LLC | NY | T | | P.a | 250 | 1.25 | 0 | 200 | 1 | 16,006 | I | | | | | | | | | | | | | | |
6/28/22 17:51 | 6/24/22 | QTNT | Quotient Ltd | Y9 | Health | Diagn | In Vitro & In Vivo Diagnostic | Mendez Manuel O. | V8 | DO | CEO | P.d | 20 | 0.3000 | 0 | 67 | 16 | 483 | D | | | | | | | | | | | | | | |
6/28/22 17:40 | 6/24/22 | QTNT | Quotient Ltd | Y9 | Health | Diagn | In Vitro & In Vivo Diagnostic | Kiboro Ali | V8 | O | CFO | P.d | 20 | 0.3000 | 0 | 67 | New | 67 | D | | | | | | | | | | | | | | |
6/17/22 18:45 | 6/16/22 | LHDX | Lucira Health, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Engelson Erik T. | CA | DO | P,Chief | P | 15 | 1.49 | 0 | 10 | 3 | 301 | D | | | | | | | | | | | | | | |
6/17/22 16:05 | 6/16/22 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Butera Salvatore Thomas | TX | O | CEO - Vo | P | 21 | 2.05 | 0 | 10 | 7 | 162 | D | | | | | | | | | | | | | | |
6/14/22 08:01 | 6/13/22 | ICCC | Immucell Corp /de/ | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cunningham David | ME | D | | P | 8 | 8.00 | 0 | 1 | 7 | 16 | D | | | | | | | | | | | | | | |
5/25/22 17:12 | 5/23/22 | ABIO | Arca Biopharma, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Funicular Fund, LP | CA | H | See Foot | P.dm | 197 | 2.32 | 0 | 85 | 3 | 2,580 | D | | | | | | | | | | | | | | |
5/23/22 17:22 | 5/20/22 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lowell Matthew | CA | O | CFO | P | 94 | 9.45 | 0 | 10 | New | 10 | D | | | | | | | | | | | | | | |
5/20/22 18:01 | 5/18/22 | ABIO | Arca Biopharma, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Funicular Fund, LP | CA | H | See Foot | P.dm | 30 | 2.30 | 0 | 13 | 1 | 2,495 | D | | | | | | | | | | | | | | |
5/18/22 09:22 | 5/16/22 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Palmieri Valerie Barber | TX | DO | Exec Cha | P | 25 | 0.5664 | 0 | 44 | 20 | 267 | D | | | | | | | | | | | | | | |
5/17/22 17:02 | 5/16/22 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sandford Nicole | TX | DO | P,CEO | P | 75 | 0.7642 | 0 | 98 | 257 | 136 | D | | | | | | | | | | | | | | |
5/17/22 11:37 | 5/16/22 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Innes Guy Archibald | TX | D | | P | 24 | 2.37 | 0 | 10 | 1 | 1,952 | D | | | | | | | | | | | | | | |
5/16/22 19:31 | 5/12/22 | ABIO | Arca Biopharma, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Funicular Fund, LP | CA | H | See Foot | P.dm | 194 | 2.29 | 0 | 85 | 4 | 2,482 | D | | | | | | | | | | | | | | |
5/11/22 18:38 | 5/10/22 | ABIO | Arca Biopharma, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Funicular Fund, LP | CA | H | See Foot | P.dm | 104 | 2.28 | 0 | 46 | 2 | 2,397 | D | | | | | | | | | | | | | | |
5/9/22 17:44 | 5/5/22 | ABIO | Arca Biopharma, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Funicular Fund, LP | CA | H | See Foot | P.dm | 283 | 2.28 | 0 | 124 | 6 | 2,352 | D | | | | | | | | | | | | | | |
5/6/22 06:00 | 5/2/22 | NYMX | Nymox Pharmaceutical Corp | | Health | Diagn | In Vitro & In Vivo Diagnostic | Robinson James George | MD | D | | P.d | 1,900 | 1.65 | 0 | 1,152 | 32 | 4,702 | D | | | | | | | | | | | | | | |
5/3/22 19:12 | 4/10/22 | NAVB | Navidea Biopharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Scott John K Jr. | OH | DT | | P.d | 0 | 0.00 | 0 | 3 | 0 | 8,107 | D | | | | | | | | | | | | | | |
5/2/22 19:03 | 4/28/22 | ABIO | Arca Biopharma, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Funicular Fund, LP | CA | H | See Foot | P.dm | 78 | 2.31 | 0 | 34 | 2 | 2,228 | D | | | | | | | | | | | | | | |
4/29/22 16:33 | 4/14/22 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Pura Vida Investments, LLC | NY | T | | P.ad | 7,888 | 1.33 | 0 | 5,932 | 49 | 18,156 | I | | | | | | | | | | | | | | |
4/27/22 18:33 | 4/25/22 | ABIO | Arca Biopharma, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Funicular Fund, LP | CA | H | See Foot | P.d | 32 | 2.29 | 0 | 14 | 1 | 2,194 | D | | | | | | | | | | | | | | |
4/20/22 19:43 | 4/18/22 | ABIO | Arca Biopharma, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Funicular Fund, LP | CA | H | See Foot | P.d | 21 | 2.31 | 0 | 9 | 0 | 2,180 | D | | | | | | | | | | | | | | |
4/18/22 21:55 | 4/14/22 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Pura Vida Investments, LLC | NY | T | | P.d | 7,888 | 1.33 | 0 | 5,932 | 49 | 18,156 | I | | | | | | | | | | | | | | |
4/15/22 18:13 | 4/14/22 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Broadwood Partners, L.P. | NY | T | | P.d | 8,000 | 1.33 | 0 | 6,004 | 15 | 46,711 | M | | | | | | | | | | | | | | |
4/14/22 20:04 | 4/14/22 | ABIO | Arca Biopharma, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Funicular Fund, LP | CA | H | See Foot | P | 41 | 2.33 | 0 | 17 | 1 | 2,171 | D | | | | | | | | | | | | | | |
4/12/22 19:31 | 4/8/22 | ABIO | Arca Biopharma, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Funicular Fund, LP | CA | H | See Foot | P.m | 243 | 2.32 | 0 | 105 | 5 | 2,154 | D | | | | | | | | | | | | | | |
4/7/22 20:38 | 4/5/22 | ABIO | Arca Biopharma, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Funicular Fund, LP | CA | H | See Foot | P.m | 240 | 2.31 | 0 | 104 | 5 | 2,049 | D | | | | | | | | | | | | | | |
4/7/22 20:36 | 4/4/22 | ABIO | Arca Biopharma, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Funicular Fund, LP | CA | H | See Foot | P.a | 276 | 2.26 | 0 | 122 | 7 | 1,945 | D | | | | | | | | | | | | | | |
4/4/22 20:26 | 4/4/22 | ABIO | Arca Biopharma, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Funicular Fund, LP | CA | H | See Foot | P | 276 | 2.26 | 0 | 122 | 7 | 1,945 | D | | | | | | | | | | | | | | |
3/28/22 20:00 | 3/25/22 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Ross Douglas T. | CA | O | Chief Sc | P | 21 | 1.40 | 0 | 15 | 282 | 20 | D | | | | | | | | | | | | | | |
3/17/22 21:27 | 3/17/22 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Paulsen Gisela | CA | O | COO | P.d | 20 | 1.20 | 0 | 17 | New | 17 | D | | | | | | | | | | | | | | |
3/17/22 21:26 | 3/16/22 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Andrews Ronald Asbury | CA | DO | CEO | P | 64 | 1.28 | 0 | 50 | 21 | 293 | D | | | | | | | | | | | | | | |
3/16/22 21:08 | 3/16/22 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Redmond Cavan M. | CA | D | | P | 48 | 1.19 | 0 | 40 | 56 | 111 | D | | | | | | | | | | | | | | |
3/16/22 18:47 | 3/15/22 | LHDX | Lucira Health, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Engelson Erik T. | CA | DO | P,Chief | P | 90 | 3.00 | 0 | 30 | 11 | 291 | D | | | | | | | | | | | | | | |
3/15/22 16:19 | 3/15/22 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Levine Mitchell S | CA | O | CFO | P | 29 | 1.17 | 0 | 25 | 40 | 87 | D | | | | | | | | | | | | | | |
2/28/22 14:40 | 2/25/22 | VIVO | Meridian Bioscience Inc | OH | Health | Diagn | In Vitro & In Vivo Diagnostic | Kitzmiller Andrew S. | OH | O | EVP,CFO | P | 100 | 24.87 | 0 | 4 | 54 | 12 | D | | | | | | | | | | | | | | |
2/25/22 16:05 | 2/23/22 | QTNT | Quotient Ltd | Y9 | Health | Diagn | In Vitro & In Vivo Diagnostic | Von Prondzynski Heino | Y9 | D | | P.dm | 78 | 1.29 | 0 | 60 | 19 | 371 | D | | | | | | | | | | | | | | |
1/28/22 18:43 | 1/25/22 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | Chief Co | P | 50 | 35.78 | 0 | 1 | 146 | 2 | D | | | | | | | | | | | | | | |
12/17/21 18:48 | 12/16/21 | QTNT | Quotient Ltd | Y9 | Health | Diagn | In Vitro & In Vivo Diagnostic | El Khoury Mohammad | V8 | O | Chief Co | P.d | 103 | 2.05 | 0 | 50 | New | 50 | D | | | | | | | | | | | | | | |
11/29/21 12:46 | 11/24/21 | MYMD | Mymd Pharmaceuticals, Inc. | NJ | Health | Diagn | In Vitro & In Vivo Diagnostic | Silverman Joshua | MD | D | | P.m | 103 | 6.89 | 0 | 15 | 20 | 89 | D | | | | | | | | | | | | | | |